Literature DB >> 27683060

Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth Assay.

Sook-Kyung Lee1, Shuntai Zhou, Pedro L Baldoni, Ean Spielvogel, Nancie M Archin, Michael G Hudgens, David M Margolis, Ronald Swanstrom.   

Abstract

BACKGROUND: In this study, we measured the latent HIV-1 reservoir harboring replication-competent HIV-1 in resting CD4 T cells in participants on highly active antiretroviral therapy, quantitating the frequency of latent infection through the use of a Primer ID-based Ultra Deep Sequencing Assay (UDSA), in comparison to the readout of the quantitative viral outgrowth assay (QVOA).
METHODS: Viral RNA derived from culture wells of QVOA that scored as HIV-1 p24 capsid antigen positive were tagged with a specific barcode during cDNA synthesis, and the sequences within the V1-V3 region of the HIV-1 env gene were analyzed for diversity using the Primer ID-based paired-end MiSeq platform. We analyzed samples from a total of 19 participants, 2 initially treated with highly active antiretroviral therapy in acute infection and 17 treated during chronic infection. Phylogenetic trees were generated with all viral lineages detected from culture wells derived from each participant to determine the number of distinct viral lineages growing out in each well, thus capturing another level of information beyond the well being positive for viral antigen. The infectious units per million (IUPM) cell values estimated using a maximum likelihood approach, based on the number of distinct viral lineages detected (VOA-UDSA), were compared with those obtained from QVOA measured using limiting dilution.
RESULTS: IUPM estimates determined by VOA-UDSA ranged from 0.14 to 3.66 and strongly correlated with the IUPM estimates determined by QVOA (r = 0.94; P < 0.0001).
CONCLUSIONS: VOA-UDSA may be an alternative readout for that currently used for QVOA.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27683060      PMCID: PMC5233602          DOI: 10.1097/QAI.0000000000001187

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  43 in total

1.  A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.

Authors:  D Persaud; T Pierson; C Ruff; D Finzi; K R Chadwick; J B Margolick; A Ruff; N Hutton; S Ray; R F Siliciano
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

3.  DNA recombination during PCR.

Authors:  A Meyerhans; J P Vartanian; S Wain-Hobson
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

4.  HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat.

Authors:  Nancy M Archin; Rosalie Bateson; Manoj K Tripathy; Amanda M Crooks; Kuo-Hsiung Yang; Noelle P Dahl; Mary F Kearney; Elizabeth M Anderson; John M Coffin; Matthew C Strain; Douglas D Richman; Kevin R Robertson; Angela D Kashuba; Ronald J Bosch; Daria J Hazuda; Joann D Kuruc; Joseph J Eron; David M Margolis
Journal:  J Infect Dis       Date:  2014-03-11       Impact factor: 5.226

5.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.

Authors:  Tae-Wook Chun; J Shawn Justement; Richard A Lempicki; Jun Yang; Glynn Dennis; Claire W Hallahan; Christina Sanford; Punita Pandya; Shuying Liu; Mary McLaughlin; Linda A Ehler; Susan Moir; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

7.  Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

Authors:  T W Chun; D Engel; M M Berrey; T Shea; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

8.  A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.

Authors:  Francesco Andrea Procopio; Rémi Fromentin; Deanna A Kulpa; Jessica H Brehm; Anne-Gaelle Bebin; Matthew C Strain; Douglas D Richman; Una O'Doherty; Sarah Palmer; Frederick M Hecht; Rebecca Hoh; Richard J O Barnard; Michael D Miller; Daria J Hazuda; Steven G Deeks; Rafick-Pierre Sékaly; Nicolas Chomont
Journal:  EBioMedicine       Date:  2015-06-27       Impact factor: 8.143

9.  Selective HDAC inhibition for the disruption of latent HIV-1 infection.

Authors:  Kirston M Barton; Nancie M Archin; Kara S Keedy; Amy S Espeseth; Yan-ling Zhang; Jennifer Gale; Florence F Wagner; Edward B Holson; David M Margolis
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

10.  Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.

Authors:  Gregory M Laird; Evelyn E Eisele; S Alireza Rabi; Jun Lai; Stanley Chioma; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

View more
  13 in total

1.  Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

Authors:  Julio C C Lorenzi; Yehuda Z Cohen; Lillian B Cohn; Edward F Kreider; John P Barton; Gerald H Learn; Thiago Oliveira; Christy L Lavine; Joshua A Horwitz; Allison Settler; Mila Jankovic; Michael S Seaman; Arup K Chakraborty; Beatrice H Hahn; Marina Caskey; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

2.  Determinants of the efficacy of HIV latency-reversing agents and implications for drug and treatment design.

Authors:  Ruian Ke; Jessica M Conway; David M Margolis; Alan S Perelson
Journal:  JCI Insight       Date:  2018-10-18

Review 3.  Viral and Host Biomarkers of HIV Remission Post Treatment Interruption.

Authors:  Leila B Giron; Mohamed Abdel-Mohsen
Journal:  Curr HIV/AIDS Rep       Date:  2022-04-19       Impact factor: 5.071

Review 4.  Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.

Authors:  Zheng Wang; Francesco R Simonetti; Robert F Siliciano; Gregory M Laird
Journal:  Retrovirology       Date:  2018-02-13       Impact factor: 4.602

5.  Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays.

Authors:  Art F Y Poon; Jessica L Prodger; Briana A Lynch; Jun Lai; Steven J Reynolds; Jingo Kasule; Adam A Capoferri; Susanna L Lamers; Christopher W Rodriguez; Daniel Bruno; Stephen F Porcella; Craig Martens; Thomas C Quinn; Andrew D Redd
Journal:  Retrovirology       Date:  2018-07-05       Impact factor: 4.602

6.  An Improved Tat/Rev Induced Limiting Dilution Assay With Enhanced Sensitivity and Breadth of Detection.

Authors:  Kavita Mehta; Yuvrajsinh Gohil; Swarnima Mishra; Anish D'silva; Afzal Amanullah; Deepak Selvam; Neelam Pargain; Narendra Nala; G N Sanjeeva; Udaykumar Ranga
Journal:  Front Immunol       Date:  2021-08-05       Impact factor: 7.561

7.  Primer ID Next-Generation Sequencing for the Analysis of a Broad Spectrum Antiviral Induced Transition Mutations and Errors Rates in a Coronavirus Genome.

Authors:  Shuntai Zhou; Collin S Hill; Michael U Clark; Timothy P Sheahan; Ralph Baric; Ronald Swanstrom
Journal:  Bio Protoc       Date:  2021-03-05

8.  Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus.

Authors:  Shuntai Zhou; Sara E Williford; David R McGivern; Christina L Burch; Fengyu Hu; Tiffany Benzine; Paul Ingravallo; Ernest Asante-Appiah; Anita Y M Howe; Ronald Swanstrom; Stanley M Lemon
Journal:  Antiviral Res       Date:  2018-08-03       Impact factor: 10.103

Review 9.  Recommendations for measuring HIV reservoir size in cure-directed clinical trials.

Authors:  Mohamed Abdel-Mohsen; Douglas Richman; Robert F Siliciano; Michel C Nussenzweig; Bonnie J Howell; Javier Martinez-Picado; Nicolas Chomont; Katharine J Bar; Xu G Yu; Mathias Lichterfeld; Jose Alcami; Daria Hazuda; Frederic Bushman; Janet D Siliciano; Michael R Betts; Adam M Spivak; Vicente Planelles; Beatrice H Hahn; Davey M Smith; Ya-Chi Ho; Maria J Buzon; Christian Gaebler; Mirko Paiardini; Qingsheng Li; Jacob D Estes; Thomas J Hope; Jay Kostman; Karam Mounzer; Marina Caskey; Lawrence Fox; Ian Frank; James L Riley; Pablo Tebas; Luis J Montaner
Journal:  Nat Med       Date:  2020-09-07       Impact factor: 87.241

10.  The HIV-1 latent reservoir is largely sensitive to circulating T cells.

Authors:  Joanna A Warren; Shuntai Zhou; Yinyan Xu; Matthew J Moeser; Daniel R MacMillan; Olivia Council; Jennifer Kirchherr; Julia M Sung; Nadia R Roan; Adaora A Adimora; Sarah Joseph; JoAnn D Kuruc; Cynthia L Gay; David M Margolis; Nancie Archin; Zabrina L Brumme; Ronald Swanstrom; Nilu Goonetilleke
Journal:  Elife       Date:  2020-10-06       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.